Skip to main content
CellaVision logo

CellaVision — Investor Relations & Filings

Ticker · CEVI ISIN · SE0000683484 LEI · 529900IUBZBZ0HXFJ114 ST Manufacturing
Open in API
Filings indexed 388 across all filing types
Latest filing 2025-11-06 Interim / Quarterly Rep…
Country SE Sweden
Listing ST CEVI

About CellaVision

https://www.cellavision.com/

CellaVision is a medical technology company that provides digital solutions for cell morphology in hematology. The company specializes in automating and standardizing the analysis of blood and other body fluids for both human and veterinary applications. Its core offerings include a complete system of analyzers, instruments, software, and reagents designed for hematology laboratories of all sizes. By utilizing patented technology that integrates automated microscopy, advanced image analysis, and artificial intelligence, CellaVision's systems digitize the traditional manual review of blood smears. This automation enhances laboratory workflow efficiency, improves diagnostic accuracy, and facilitates remote collaboration among healthcare professionals, advancing diagnostic certainty.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2025
Interim / Quarterly Report Classification · 1% confidence The document is a 'Delårsrapport' (Interim Report) for CellaVision covering the period January-September 2025. It contains detailed financial statements, including income statements, cash flow analysis, and management commentary on regional performance and strategic progress. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2025
2025-11-06 Swedish
Interim / Quarterly Report 2025
Interim / Quarterly Report Classification · 1% confidence The document is titled 'CellaVision Interim Report January–September 2025'. It contains comprehensive financial statements, including income statements, cash flow analysis, and detailed management commentary on regional performance, sales, and strategic progress for the nine-month period. It is clearly a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q3 2025
2025-11-06 English
Nomination Committee for the CellaVision Annual General Meeting 2026
Board/Management Information Classification · 1% confidence The document announces the composition of the Nomination Committee for the upcoming 2026 Annual General Meeting and provides instructions for shareholders to submit proposals. It is a preparatory announcement related to the AGM process rather than the meeting materials themselves or a report publication announcement. Given the focus on board/committee composition and meeting preparation, it fits best under the general regulatory announcement category as it does not strictly fall into the AGM-R (presentation materials) or PSI (proxy solicitation) categories.
2025-10-21 English
Valberedning utsedd inför CellaVisions årsstämma 2026
AGM Information Classification · 1% confidence The document is a short announcement (under 2,500 characters) regarding the appointment of a nomination committee ('Valberedning') for the upcoming 2026 Annual General Meeting. It provides details on the committee members and instructions for shareholders, and includes a link to a PDF file. Per the 'Menu vs Meal' rule, this is an announcement regarding corporate governance preparations rather than the full AGM report or proxy statement itself, making it a Regulatory Filing (RNS) or a general corporate announcement.
2025-10-21 Swedish
CellaVision utser Monica Jönsson till Interim CFO
Board/Management Information Classification · 1% confidence The document is a press release announcing the appointment of a new Interim CFO at CellaVision. This falls under the category of management changes, which is explicitly defined as 'Board/Management Information' (MANG).
2025-09-02 Swedish
CellaVision appoints Monica Jönsson as Interim CFO
Board/Management Information Classification · 1% confidence The document is a press release announcing the appointment of a new Interim CFO at CellaVision. This falls under the category of management changes, which is explicitly defined as 'Board/Management Information' (MANG).
2025-09-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.